|
JP4033494B2
(ja)
*
|
1996-07-26 |
2008-01-16 |
ギリヤド サイエンシーズ， インコーポレイテッド |
ヌクレオチドアナログ
|
|
PT1256584E
(pt)
*
|
1997-07-25 |
2004-12-31 |
Gilead Sciences Inc |
Processo para a preparacao de adefovir-dipivoxil
|
|
EP1243593B1
(en)
*
|
1997-07-25 |
2005-09-21 |
Gilead Sciences, Inc. |
Nucleotide analog composition and synthesis method
|
|
WO1999005150A1
(en)
*
|
1997-07-25 |
1999-02-04 |
Gilead Sciences, Inc. |
Nucleotide analog composition and synthesis method
|
|
AU4716299A
(en)
*
|
1998-06-24 |
2000-01-10 |
Emory University |
Use of 3'-azido-2',3'-dideoxyuridine in combination with further anti-hiv drugs for the manufacture of a medicament for the treatment of hiv
|
|
CZ304734B6
(cs)
*
|
2000-07-21 |
2014-09-10 |
Gilead Sciences, Inc. |
Způsob přípravy 9-[2-(fosfonomethoxy)propyl]adeninu a 9-[2-(fosfonomethoxy)ethyl]adeninu
|
|
CA2481449A1
(en)
|
2002-04-26 |
2003-11-06 |
Gilead Sciences, Inc. |
Method and compositions for identifying anti-hiv therapeutic compounds
|
|
EP1923063A3
(en)
|
2003-01-14 |
2009-04-08 |
Gilead Sciences, Inc. |
Compositions and methods for combination antiviral therapy
|
|
US7432261B2
(en)
|
2003-04-25 |
2008-10-07 |
Gilead Sciences, Inc. |
Anti-inflammatory phosphonate compounds
|
|
US7452901B2
(en)
|
2003-04-25 |
2008-11-18 |
Gilead Sciences, Inc. |
Anti-cancer phosphonate analogs
|
|
US7273716B2
(en)
|
2003-04-25 |
2007-09-25 |
Gilead Sciences, Inc. |
Methods and compositions for identifying therapeutic compounds with GS-7340 ester hydrolase
|
|
US7427636B2
(en)
|
2003-04-25 |
2008-09-23 |
Gilead Sciences, Inc. |
Inosine monophosphate dehydrogenase inhibitory phosphonate compounds
|
|
WO2004096285A2
(en)
|
2003-04-25 |
2004-11-11 |
Gilead Sciences, Inc. |
Anti-infective phosphonate conjugates
|
|
CN101410120A
(zh)
*
|
2003-04-25 |
2009-04-15 |
吉里德科学公司 |
抗炎的膦酸酯化合物
|
|
US7470724B2
(en)
|
2003-04-25 |
2008-12-30 |
Gilead Sciences, Inc. |
Phosphonate compounds having immuno-modulatory activity
|
|
US7407965B2
(en)
|
2003-04-25 |
2008-08-05 |
Gilead Sciences, Inc. |
Phosphonate analogs for treating metabolic diseases
|
|
EP1620109A2
(en)
|
2003-04-25 |
2006-02-01 |
Gilead Sciences, Inc. |
Kinase inhibitor phosphonate conjugates
|
|
NZ542342A
(en)
|
2003-04-25 |
2009-05-31 |
Gilead Sciences Inc |
Antiviral phosphonate analogs
|
|
WO2005002626A2
(en)
|
2003-04-25 |
2005-01-13 |
Gilead Sciences, Inc. |
Therapeutic phosphonate compounds
|
|
ATE496056T1
(de)
|
2003-06-16 |
2011-02-15 |
Acad Of Science Czech Republic |
Pyrimidinverbindungen mit phosphonatgruppen als antivirale nucleotidanaloga
|
|
WO2005044279A1
(en)
|
2003-10-24 |
2005-05-19 |
Gilead Sciences, Inc. |
Purine nucleoside phosphonate conjugates
|
|
WO2005044308A1
(en)
|
2003-10-24 |
2005-05-19 |
Gilead Sciences, Inc. |
Phosphonate analogs of antimetabolites
|
|
EP1715871A1
(en)
*
|
2003-12-22 |
2006-11-02 |
Gilead Sciences, Inc. |
Kinase inhibitor phosphonate conjugates
|
|
WO2005063751A1
(en)
|
2003-12-22 |
2005-07-14 |
Gilead Sciences, Inc. |
4’-substituted carbovir-and abacavir-derivatives as well as related compounds with hiv and hcv antiviral activity
|
|
AU2005330489B2
(en)
|
2004-07-27 |
2011-08-25 |
Gilead Sciences, Inc. |
Nucleoside phosphonate conjugates as anti HIV agents
|
|
CN102228463B
(zh)
*
|
2005-06-13 |
2012-12-19 |
博瑞生物医药技术(苏州)有限公司 |
泰诺福韦的晶体
|
|
TWI375560B
(en)
|
2005-06-13 |
2012-11-01 |
Gilead Sciences Inc |
Composition comprising dry granulated emtricitabine and tenofovir df and method for making the same
|
|
TWI471145B
(zh)
|
2005-06-13 |
2015-02-01 |
Bristol Myers Squibb & Gilead Sciences Llc |
單一式藥學劑量型
|
|
CA2681267C
(en)
|
2007-04-13 |
2013-11-19 |
Southern Research Institute |
Anti-angiogenic agents and methods of use
|
|
CN101778855A
(zh)
*
|
2007-05-22 |
2010-07-14 |
阿尔迪默菲克斯技术有限责任公司 |
替诺福韦酯半富马酸共晶体
|
|
WO2009064174A1
(en)
*
|
2007-11-14 |
2009-05-22 |
Ultimorphix Technologies B.V. |
Polymorphic form of tenofovir disoproxil fumarate, method for its preparation and use
|
|
EP2937356A1
(en)
*
|
2008-04-25 |
2015-10-28 |
Cipla Limited |
Crystalline form of tenofovir disoproxil and a process for its preparation
|
|
WO2010005986A1
(en)
|
2008-07-08 |
2010-01-14 |
Gilead Sciences, Inc. |
Salts of hiv inhibitor compounds
|
|
CN102093422B
(zh)
|
2009-12-10 |
2015-02-25 |
中国人民解放军军事医学科学院毒物药物研究所 |
无环核苷膦酸酯衍生物及其医药用途
|
|
WO2012152317A1
(en)
*
|
2011-05-10 |
2012-11-15 |
Okapi Sciences Nv |
Compounds for use in the treatment of feline retroviral infections
|
|
CA2845553C
(en)
|
2011-08-16 |
2019-05-28 |
Gilead Sciences, Inc. |
Tenofovir alafenamide hemifumarate
|
|
CN103626802A
(zh)
*
|
2012-08-23 |
2014-03-12 |
重庆药友制药有限责任公司 |
一种制备替诺福韦的新方法
|
|
CN103665043B
(zh)
|
2012-08-30 |
2017-11-10 |
江苏豪森药业集团有限公司 |
一种替诺福韦前药及其在医药上的应用
|
|
WO2014068265A1
(en)
|
2012-10-29 |
2014-05-08 |
Cipla Limited |
Antiviral phosphonate analogues and process for preparation thereof
|
|
EP2860184B1
(en)
|
2013-10-09 |
2018-08-29 |
Zentiva, k.s. |
Dihydrogenphosphate salt of Tenofovir disoproxil
|
|
EP2860185A1
(en)
|
2013-10-09 |
2015-04-15 |
Zentiva, k.s. |
An improved process for the preparation of Tenofovir disoproxil and pharmaceutically acceptable salts thereof
|
|
TWI660965B
(zh)
*
|
2014-01-15 |
2019-06-01 |
美商基利科學股份有限公司 |
泰諾福韋之固體形式
|
|
SI3661937T1
(sl)
|
2017-08-01 |
2021-11-30 |
Gilead Sciences, Inc. |
Kristalinične oblike etil((S)-((((2R,5R)-5-(6-amino-9H-purin-9-IL)-4- fluoro-2,5-dihidrofuran-2-IL)oksi)metil)(fenoksi)fosforil)-L-alaninata (GS-9131) za zdravljenje virusnih okužb
|
|
CN107805202A
(zh)
*
|
2017-12-01 |
2018-03-16 |
内蒙古圣氏化学股份有限公司 |
一种氯甲基异丙基碳酸酯连续化反应装置及方法
|
